MANGOCEUTICALS, INC.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
MGRX$0.20+1.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statement of Changes in Stockholders’ Equity
For the Three Months Ended March 31, 2025 and 2024
| Preferred B Stock · Preferred C Stock · Common Stock · Stock · Subscriptions · Additional Paid-in · Accumulated · Total Comprehensive · Non-Controlling · Stockholders’ | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Shares* · Amount · Warrants · Receivable · Capital · Deficit · Loss · Interest · Equity | |||||||||||||||||||
| Balance, December 31, 2023 | - | $ | - | - | $ | - | 1,427,967 | 148 | $ | - | $ | - | $12,002,779 | $(11,228,173) | $ | - | $ | - | $774,754 |
| Issuance of common stock for services | - | - | - | - | 106,667 | 11 | - | - | 416,489 | - | - | - | 416,500 | ||||||
| Issuance of common stock for cash | - | - | - | - | 40,000 | 4 | - | - | 179,996 | - | - | - | 180,000 | ||||||
| Options and warrants vested for services | - | - | - | - | - | - | - | - | 37,965 | - | - | - | 37,965 | ||||||
| Translation adjustment | - | - | - | - | - | - | - | - | - | - | (70) | - | (70) | ||||||
| Net loss | - | - | - | - | - | - | - | - | - | (2,367,581) | - | (36) | (2,367,617) | ||||||
| Balance, March 31, 2024 | - | $ | - | - | $ | - | 1,574,634 | $163 | $ | - | $ | - | $12,637,229 | $(13,595,754) | $(70) | $(36) | $(958,468) | ||
| Balance December 31, 2024 | 2,770 | $ | - | 980,000 | $98 | $3,245,641 | $325 | $324,288 | $(1,150,000) | $35,587,858 | $(20,806,595) | $(9,845) | $(1,081) | $13,945,048 | |||||
| Issuance of preferred stock B for cash | - | - | - | - | - | - | - | 1,150,000 | - | - | - | - | 1,150,000 | ||||||
| Issuance of common stock for services | - | - | - | - | 522,000 | 52 | - | - | 1,938,448 | - | - | - | 1,938,500 | ||||||
| Issuance of common stock for cash | - | - | - | - | 305,555 | 31 | - | - | 654,969 | - | - | - | 655,000 | ||||||
| Warrants exercised for cash | - | - | - | - | 320,000 | 32 | - | - | 479,968 | - | - | - | 480,000 | ||||||
| Issuance of common stock for master distribution agreement | - | - | - | - | 1,650,000 | 165 | - | - | 6,712,835 | - | - | - | 6,713,000 | ||||||
| Issuance of common stock for debt | - | - | - | - | 100,000 | 10 | - | - | 149,990 | - | - | - | 150,000 | ||||||
| Conversion of preferred stock B for common stock | (1,438) | - | - | - | - | - | - | - | (1,581,812) | - | - | - | (1,581,812) | ||||||
| Issuance of common stock for conversion of preferred stock B | - | - | - | - | 1,001,734 | 100 | - | - | 1,581,712 | - | - | - | 1,581,812 | ||||||
| Options and warrants vested for services | - | - | - | - | - | - | - | - | 50,979 | - | - | - | 50,979 | ||||||
| Preferred stock C accrued dividend | - | - | - | - | - | - | - | - | 294,000 | (294,000) | - | - | - | ||||||
| Translation adjustment | - | - | - | - | - | - | - | - | - | - | 7,624 | - | 7,624 | ||||||
| Net loss | - | - | - | - | - | - | - | - | - | (4,839,391) | - | (98) | (4,839,489) | ||||||
| Balance, March 31, 2025 | 1,332 | - | 980,000 | $98 | 7,144,930 | 715 | 324,288 | - | 45,868,946 | (25,939,986) | (2,221) | (1,179) | 20,250,661 | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.